🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Influenza split vaccine

Found 241 matching trials

Entolimod on Immunosenescence in Healthy Geriatric Subjects Receiving Influenza Vaccination

PHASE2

Researchers are evaluating the safety and effectiveness of a single adminis...

Status

Completed

Location

Mayo Clinic in Rochester

Start Date

2019-10-30

Trial ID

NCT04176133

Treatments Being Tested

Entolimod Placebo Influenza vaccine

Preliminary Study on Safety and Immunogenicity of Influenza A (H7N9) Vaccine in the Population

PHASE1

Adopt the design of random, blind method and placebo to parallel control an...

Status

Completed

Location

Multiple Locations

Start Date

2015-11-06

Trial ID

NCT03196661

Treatments Being Tested

Influenza A (H7N9) virus vaccine

Trial of Tolerability, Safety and Immunogenicity of the Flu-M Vaccine in Children Between 6 Months and 9 Years Old

PHASE3

Comparative trial of tolerability, reactogenicity, safety and immunogenicit...

Status

Completed

Location

LLC "Energiya zdorov'ya"

Start Date

2021-02-16

Trial ID

NCT05470582

Treatments Being Tested

Flu-M, Inactivated split influenza vaccine 0.5 mL Vaxigrip, Inactivated split influenza vaccine 0.5 mL Flu-M, Inactivated split influenza vaccine 0.25 mL Vaxigrip, Inactivated split influenza vaccine 0.25 mL

Study of Inactivated, Split-Virion Influenza Vaccine Compared With Standard Fluzone Vaccine in Infants and Children

PHASE2

Primary Objective: To evaluate for each influenza strain the non-inferiori...

Status

Completed

Location

Multiple Locations

Start Date

2006-10

Trial ID

NCT00391391

Treatments Being Tested

Split, Inactivated, Trivalent Influenza Vaccine Split, Inactivated, Trivalent Influenza Vaccine Split, Inactivated, Trivalent Influenza Vaccine ( Fluzone® 2006/2007 Formulation)Split, Inactivated, Trivalent Influenza Vaccine ( Fluzone® 2006/2007 Formulation)

Zanamivir Versus Trivalent Split Virus Influenza Vaccine

PHASE3

This unblinded pilot study is intended to assess the feasibility of a large...

Status

Completed

Location

Mount Sinai Hospital

Start Date

2008-11

Trial ID

NCT00784784

Treatments Being Tested

Fluviral Zanamivir

Reactogenicity, Safety and Immunogenicity Study of a Allantoic Split Inactivated Seasonal Influenza Vaccine

PHASE1

The study is a single centre, phase I, double-blind, randomized, placebo-co...

Status

Completed

Location

Kazakh National Medical University

Start Date

2016-05

Trial ID

NCT03028116

Treatments Being Tested

influenza vaccine Placebo

Safety and Immunogenicity of a Split-Virion Pandemic Influenza A (H5N1) Vaccine in Adolescents

PHASE2

A single center, stratified, randomized and double-blind phase II clinical ...

Status

Completed

Location

Beijing Centers for Diseases Control and Prevention

Start Date

TBD

Trial ID

NCT00900588

Treatments Being Tested

split-virion pandemic influenza vaccine (H5N1 strain NIBRG-14)

High vs.Standard Dose Influenza Vaccine in Pediatric Solid Organ Transplant (SOT) Recipients

PHASE2

Influenza virus is a significant pathogen in pediatric solid organ transpla...

Status

Recruiting

Location

Stanford University

Start Date

2024-09-26

Trial ID

NCT05947071

Treatments Being Tested

Standard Dose Quadrivalent Inactivated Influenza Vaccine High Dose Quadrivalent Inactivated Influenza Vaccine

Study of the Influenza Vaccine (Split Virion, Inactivated) Northern Hemisphere 2009-2010 Formulation (Intradermal Route)

PHASE2

This study is in support of the annual application for the variation of the...

Status

Completed

Location

Multiple Locations

Start Date

2009-05

Trial ID

NCT00945438

Treatments Being Tested

Influenza virus vaccine 2009-2010 formulation Influenza virus vaccine 2009-2010 formulation

Efficacy Study of an Investigational Influenza Vaccine (Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection (CCII)

PHASE3

The primary purpose of this study is to demonstrate the efficacy of an inve...

Status

Completed

Location

Multiple Locations

Start Date

2007-11

Trial ID

NCT00566345

Treatments Being Tested

Inactivated seasonal influenza vaccine (split virus, Vero cell-derived)Phosphate buffered saline

Previous Next